Free Trial

Cognex (CGNX) Financials

Cognex logo
$24.99 +0.82 (+3.39%)
Closing price 04/23/2025 03:59 PM Eastern
Extended Trading
$24.93 -0.06 (-0.24%)
As of 04/23/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Cognex

Annual Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
187 144 177 219 204 176 280 216 113 106
Consolidated Net Income / (Loss)
187 144 177 219 204 176 280 216 113 106
Net Income / (Loss) Continuing Operations
108 144 177 219 204 176 280 216 113 106
Total Pre-Tax Income
127 162 266 235 163 187 319 251 135 131
Total Operating Income
122 154 259 221 143 171 315 246 131 115
Total Gross Profit
348 398 579 600 536 605 760 722 601 626
Total Revenue
451 530 766 806 726 811 1,037 1,006 838 915
Operating Revenue
451 530 766 806 726 811 1,037 1,006 838 915
Total Cost of Revenue
103 131 187 206 190 206 277 284 236 289
Operating Cost of Revenue
103 131 187 206 190 206 277 284 236 289
Total Operating Expenses
226 244 320 379 393 434 445 476 471 511
Selling, General & Admin Expense
157 166 221 263 274 268 309 312 339 371
Research & Development Expense
70 78 99 116 119 131 135 141 139 140
Other Operating Expenses / (Income)
- - - - - - 0.00 21 -8.00 0.00
Restructuring Charge
- - - 0.00 0.00 16 0.00 1.66 0.00 0.00
Total Other Income / (Expense), net
5.44 8.01 7.60 13 20 16 3.80 4.47 4.65 16
Interest & Investment Income
3.67 7.04 9.54 15 20 13 6.66 6.72 14 14
Other Income / (Expense), net
1.77 0.97 -1.94 -1.28 0.70 3.39 -2.86 -2.25 -9.45 2.45
Income Tax Expense
19 18 90 15 -41 11 39 35 22 25
Basic Earnings per Share
$1.08 $0.84 $1.02 $1.27 $1.19 $1.02 $1.59 $1.24 $0.66 $0.62
Weighted Average Basic Shares Outstanding
172.59M 170.68M 173.29M 172.33M 171.19M 173.49M 176.46M 173.41M 172.25M 171.44M
Diluted Earnings per Share
$1.06 $0.83 $0.98 $1.24 $1.16 $1.00 $1.56 $1.23 $0.65 $0.62
Weighted Average Diluted Shares Outstanding
175.98M 174.14M 179.55M 177.41M 175.27M 176.59M 179.92M 174.87M 173.40M 172.61M
Weighted Average Basic & Diluted Shares Outstanding
86.20M 170M 173.20M 172.70M 172.61M 352.06M 347.83M 345.07M 343.27M 169.87M
Cash Dividends to Common per Share
$0.11 $0.15 $0.17 $0.19 $0.21 $2.23 $0.25 $0.27 $0.29 $0.31

Quarterly Income Statements for Cognex

This table shows Cognex's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
34 55 26 57 19 11 12 36 30 28
Consolidated Net Income / (Loss)
34 55 26 57 19 11 12 36 30 28
Net Income / (Loss) Continuing Operations
34 55 26 57 19 11 12 36 30 28
Total Pre-Tax Income
39 59 26 68 27 14 18 42 37 36
Total Operating Income
40 54 22 65 31 13 14 38 32 31
Total Gross Profit
152 170 144 180 143 135 142 167 159 158
Total Revenue
210 239 201 243 197 197 211 239 235 230
Operating Revenue
210 239 201 243 197 197 211 239 235 230
Total Cost of Revenue
57 70 57 63 54 62 69 73 75 72
Operating Cost of Revenue
57 70 57 63 54 62 69 73 75 72
Total Operating Expenses
112 115 122 115 112 122 128 128 128 127
Selling, General & Admin Expense
75 76 83 83 82 90 91 93 93 94
Research & Development Expense
34 37 39 34 33 35 37 35 35 33
Total Other Income / (Expense), net
-0.68 4.89 4.05 2.60 -3.64 1.63 3.36 3.11 4.99 4.96
Interest & Investment Income
1.42 2.33 3.59 4.10 4.89 1.52 3.12 3.12 3.56 4.17
Other Income / (Expense), net
-2.09 2.57 0.47 -1.49 -8.53 0.11 0.24 -0.01 1.43 0.79
Income Tax Expense
5.37 3.92 0.60 10 8.09 3.13 5.54 5.36 6.96 7.45
Basic Earnings per Share
$0.20 $0.31 $0.15 $0.33 $0.11 $0.07 $0.07 $0.21 $0.17 $0.17
Weighted Average Basic Shares Outstanding
173.26M 173.41M 172.62M 172.43M 172.17M 172.25M 171.69M 171.57M 171.52M 171.44M
Diluted Earnings per Share
$0.19 $0.32 $0.15 $0.33 $0.11 $0.06 $0.07 $0.21 $0.17 $0.17
Weighted Average Diluted Shares Outstanding
174.33M 174.87M 173.90M 173.62M 173.35M 173.40M 172.59M 172.73M 172.75M 172.61M
Weighted Average Basic & Diluted Shares Outstanding
172.93M 345.07M 172.60M 172.29M 172.14M 343.27M 171.66M 171.50M 171.52M 169.87M
Cash Dividends to Common per Share
$0.07 $0.07 $0.07 $0.07 $0.07 $0.08 $0.08 $0.08 $0.08 $0.08

Annual Cash Flow Statements for Cognex

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-3.72 28 27 2.72 63 98 -83 -4.79 21 -17
Net Cash From Operating Activities
128 182 224 223 253 242 314 243 113 149
Net Cash From Continuing Operating Activities
128 182 224 223 253 242 314 243 113 149
Net Income / (Loss) Continuing Operations
187 144 177 219 204 176 280 216 113 106
Consolidated Net Income / (Loss)
187 144 177 219 204 176 280 216 113 106
Depreciation Expense
9.87 12 14 18 22 22 17 16 17 21
Amortization Expense
4.94 3.77 3.51 3.18 2.76 5.64 8.55 8.24 6.36 12
Non-Cash Adjustments To Reconcile Net Income
-58 19 32 43 57 72 48 106 63 49
Changes in Operating Assets and Liabilities, net
-15 3.63 -1.17 -60 -32 -34 -39 -103 -87 -39
Net Cash From Investing Activities
-11 -122 -106 -11 -157 169 -253 -4.45 32 -39
Net Cash From Continuing Investing Activities
-11 -122 -106 -11 -157 169 -253 -4.45 32 -39
Purchase of Property, Plant & Equipment
-18 -13 -29 -37 -22 -13 -15 -20 -23 -15
Acquisitions
-11 -14 -24 -4.27 -167 1.00 0.00 -5.05 -257 -1.44
Purchase of Investments
-687 -752 -637 -782 -1,032 -923 -668 -234 -184 -851
Sale and/or Maturity of Investments
601 657 584 813 1,063 1,105 431 254 496 828
Net Cash From Financing Activities
-117 -29 -100 -210 -32 -317 -142 -240 -126 -118
Net Cash From Continuing Financing Activities
-117 -29 -100 -210 -32 -317 -142 -240 -126 -118
Repurchase of Common Equity
-126 -47 -124 -204 -62 -51 -162 -204 -80 -67
Payment of Dividends
-18 -25 -29 -32 -35 -391 -43 -46 -49 -52
Issuance of Common Equity
28 43 55 27 65 126 63 9.86 3.27 0.99
Effect of Exchange Rate Changes
-4.67 -3.35 8.29 - -0.52 2.67 -2.82 -3.37 1.70 -8.25

Quarterly Cash Flow Statements for Cognex

This table details how cash moves in and out of Cognex's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
89 -85 -17 13 218 -193 -64 38 20 -11
Net Cash From Operating Activities
84 66 28 30 41 14 14 28 56 51
Net Cash From Continuing Operating Activities
84 66 28 30 41 14 14 28 56 51
Net Income / (Loss) Continuing Operations
34 55 26 57 19 11 12 36 30 28
Consolidated Net Income / (Loss)
34 55 26 57 19 11 12 36 30 28
Depreciation Expense
4.06 4.17 3.99 4.19 4.38 4.71 5.28 5.19 5.43 5.37
Amortization Expense
2.07 1.80 1.64 1.24 0.89 2.58 3.12 2.98 3.26 2.36
Non-Cash Adjustments To Reconcile Net Income
16 14 17 13 14 19 15 15 13 6.49
Changes in Operating Assets and Liabilities, net
27 -9.14 -21 -46 2.94 -23 -21 -31 4.49 8.84
Net Cash From Investing Activities
47 -127 -5.79 17 200 -179 -49 35 -27 2.23
Net Cash From Continuing Investing Activities
47 -127 -5.79 17 200 -179 -49 35 -27 2.23
Purchase of Property, Plant & Equipment
-4.35 -4.06 -5.51 -4.70 -5.86 -7.02 -4.06 -4.51 -4.40 -2.07
Purchase of Investments
- -156 -46 -48 -80 -9.73 -234 -36 -379 -202
Sale and/or Maturity of Investments
51 38 46 70 286 94 190 76 356 206
Net Cash From Financing Activities
-36 -32 -39 -31 -22 -33 -25 -22 -15 -56
Net Cash From Continuing Financing Activities
-36 -32 -39 -31 -22 -33 -25 -22 -15 -56
Repurchase of Common Equity
-24 -26 -24 -25 -10 -20 -9.34 -11 -3.96 -43
Payment of Dividends
-11 -12 -12 -12 -12 -13 -13 -13 -13 -14
Issuance of Common Equity
-0.19 5.64 -3.06 5.71 0.62 -0.01 -2.86 0.99 1.67 1.20
Effect of Exchange Rate Changes
-5.95 8.45 0.36 -2.47 -1.38 5.19 -3.33 -2.82 6.75 -8.86

Annual Balance Sheets for Cognex

This table presents Cognex's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
888 1,039 1,288 1,290 1,886 1,801 2,004 1,958 2,018 1,993
Total Current Assets
444 526 630 780 607 602 640 718 679 613
Cash & Equivalents
52 80 107 108 171 269 186 181 203 186
Short-Term Investments
296 341 298 427 240 103 137 219 129 60
Accounts Receivable
43 58 127 127 108 131 134 128 117 146
Inventories, net
37 27 68 83 60 61 113 122 162 158
Prepaid Expenses
16 21 31 34 27 37 69 67 68 63
Plant, Property, & Equipment, net
53 54 78 91 89 79 78 80 106 98
Total Noncurrent Assets
390 458 580 418 1,189 1,120 1,286 1,161 1,233 1,281
Long-Term Investments
273 324 423 262 433 395 584 454 244 341
Goodwill
81 95 113 113 243 244 242 243 393 385
Intangible Assets
6.32 8.31 13 10 39 16 12 12 113 91
Noncurrent Deferred & Refundable Income Taxes
27 28 27 29 450 435 419 407 400 392
Other Noncurrent Operating Assets
2.61 2.32 2.49 3.93 23 30 30 44 82 72
Total Liabilities & Shareholders' Equity
888 1,039 1,288 1,290 1,886 1,801 2,004 1,958 2,018 1,993
Total Liabilities
62 76 192 154 530 539 574 520 513 475
Total Current Liabilities
54 66 113 91 120 132 189 188 152 169
Accounts Payable
7.86 9.83 23 16 18 16 44 27 21 38
Accrued Expenses
33 43 68 60 52 77 92 93 72 72
Current Deferred Revenue
12 8.21 9.42 9.85 14 21 36 41 32 25
Current Deferred & Payable Income Tax Liabilities
0.99 5.19 12 5.06 30 9.38 8.58 18 17 26
Other Current Liabilities
- - - 0.00 5.65 8.11 7.79 8.45 9.62 8.85
Total Noncurrent Liabilities
8.40 10 79 63 410 406 385 332 361 306
Noncurrent Deferred Revenue
- 0.00 67 51 51 49 43 33 18 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
5.15 5.36 6.80 8.07 344 329 309 266 274 244
Other Noncurrent Operating Liabilities
3.25 4.87 5.90 3.87 15 28 33 33 69 63
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518
Total Preferred & Common Equity
826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518
Preferred Stock
- - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518
Common Stock
311 375 462 530 640 808 915 980 1,038 1,091
Retained Earnings
567 644 669 646 753 488 563 528 513 499
Accumulated Other Comprehensive Income / (Loss)
-52 -56 -35 -41 -37 -34 -48 -69 -45 -73

Quarterly Balance Sheets for Cognex

This table presents Cognex's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,900 1,974 1,998 1,990 2,013 2,004 2,063
Total Current Assets
787 722 718 847 662 681 672
Cash & Equivalents
266 164 177 396 139 177 197
Short-Term Investments
208 217 191 117 139 112 91
Accounts Receivable
98 147 150 132 141 161 160
Inventories, net
109 127 126 134 171 157 155
Prepaid Expenses
106 68 73 68 71 74 69
Plant, Property, & Equipment, net
79 81 82 83 104 103 103
Total Noncurrent Assets
1,033 1,171 1,198 1,060 1,248 1,220 1,288
Long-Term Investments
343 463 463 333 278 266 319
Goodwill
238 242 242 241 386 381 392
Intangible Assets
9.42 11 11 9.99 105 99 103
Noncurrent Deferred & Refundable Income Taxes
405 410 407 403 398 397 395
Other Noncurrent Operating Assets
38 44 75 73 80 78 79
Total Liabilities & Shareholders' Equity
1,900 1,974 1,998 1,990 2,013 2,004 2,063
Total Liabilities
511 528 518 501 524 497 496
Total Current Liabilities
161 214 180 170 188 169 171
Accounts Payable
22 27 26 23 27 23 30
Accrued Expenses
64 84 84 79 70 75 77
Current Deferred Revenue
55 58 43 40 40 41 30
Current Deferred & Payable Income Tax Liabilities
12 38 19 19 40 21 24
Other Current Liabilities
8.11 8.18 8.19 7.98 9.80 9.41 9.81
Total Noncurrent Liabilities
350 314 337 332 336 329 325
Noncurrent Deferred & Payable Income Tax Liabilities
272 264 257 253 268 263 257
Other Noncurrent Operating Liabilities
78 50 81 79 68 66 69
Commitments & Contingencies
- - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,389 1,446 1,480 1,489 1,489 1,507 1,567
Total Preferred & Common Equity
1,389 1,446 1,480 1,489 1,489 1,507 1,567
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,389 1,446 1,480 1,489 1,489 1,507 1,567
Common Stock
961 993 1,011 1,024 1,048 1,062 1,077
Retained Earnings
511 518 538 534 502 515 528
Accumulated Other Comprehensive Income / (Loss)
-82 -64 -69 -70 -61 -70 -38

Annual Metrics and Ratios for Cognex

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
5.65% 17.52% 44.68% 5.25% -10.01% 11.77% 27.88% -2.99% -16.75% 9.19%
EBITDA Growth
-3.36% 23.46% 60.78% -11.89% -30.61% 20.35% 67.29% -20.40% -46.05% 3.89%
EBIT Growth
-4.13% 25.75% 65.72% -14.43% -34.82% 21.36% 79.53% -21.86% -50.30% -3.08%
NOPAT Growth
-4.19% 32.78% 25.46% 20.41% -13.72% -9.88% 72.04% -23.45% -48.34% -15.03%
Net Income Growth
53.99% -23.19% 22.98% 24.08% -7.02% -13.58% 58.86% -22.99% -47.46% -6.24%
EPS Growth
53.99% -23.19% 18.07% 26.53% -6.45% -13.79% 56.00% -21.15% -47.15% -4.62%
Operating Cash Flow Growth
-21.68% 41.89% 23.20% -0.39% 13.36% -4.31% 29.56% -22.50% -53.61% 32.03%
Free Cash Flow Firm Growth
-43.20% 74.66% -1.73% 12.62% -95.86% 3,011.83% 40.97% -39.55% -256.37% 138.82%
Invested Capital Growth
18.81% 6.51% 23.12% 26.14% 51.14% -3.06% 5.65% 11.75% 58.95% 0.18%
Revenue Q/Q Growth
2.01% 8.24% 6.22% 1.30% -3.14% 7.11% 2.01% -0.46% -4.86% 3.75%
EBITDA Q/Q Growth
-2.35% 8.62% 6.33% -1.58% -13.04% 28.43% -2.12% 0.05% -22.78% 14.65%
EBIT Q/Q Growth
-2.84% 9.42% 6.50% -2.22% -15.50% 34.35% -2.08% 0.24% -26.66% 19.03%
NOPAT Q/Q Growth
-4.10% 10.66% -24.92% 48.87% 17.09% -3.56% -4.06% -0.57% -27.30% 18.41%
Net Income Q/Q Growth
-4.04% 10.48% -25.39% 50.08% 20.66% -5.87% -5.35% 0.83% -28.02% 19.22%
EPS Q/Q Growth
-4.04% 10.48% -28.47% 45.88% 17.17% -7.41% -6.02% 1.65% -28.57% 21.57%
Operating Cash Flow Q/Q Growth
-30.58% 20.59% 4.11% -5.30% -1.56% 6.69% -8.12% 4.75% -31.43% 32.91%
Free Cash Flow Firm Q/Q Growth
-42.98% 17.33% 15.93% -15.15% -96.70% 3,440.33% -9.09% 0.93% -397.31% 138.26%
Invested Capital Q/Q Growth
-7.27% -8.83% -26.14% -0.72% 59.09% 0.41% 2.99% 2.20% 44.41% -3.09%
Profitability Metrics
- - - - - - - - - -
Gross Margin
77.23% 75.25% 75.55% 74.45% 73.85% 74.55% 73.26% 71.75% 71.79% 68.43%
EBITDA Margin
30.65% 32.20% 35.78% 29.95% 23.10% 24.87% 32.53% 26.69% 17.30% 16.46%
Operating Margin
26.97% 29.10% 33.79% 27.43% 19.65% 21.03% 30.38% 24.47% 15.61% 12.58%
EBIT Margin
27.36% 29.28% 33.54% 27.27% 19.75% 21.44% 30.11% 24.25% 14.48% 12.85%
Profit (Net Income) Margin
41.52% 27.14% 23.07% 27.19% 28.10% 21.72% 26.99% 21.42% 13.52% 11.61%
Tax Burden Percent
147.35% 88.66% 66.32% 93.47% 125.08% 94.26% 87.76% 85.97% 83.66% 80.75%
Interest Burden Percent
102.98% 104.54% 103.71% 106.69% 113.74% 107.47% 102.13% 102.75% 111.62% 111.89%
Effective Tax Rate
15.20% 11.18% 33.68% 6.53% -25.08% 5.74% 12.24% 14.03% 16.34% 19.25%
Return on Invested Capital (ROIC)
54.82% 64.92% 70.77% 68.29% 42.06% 31.99% 54.36% 38.25% 14.46% 10.00%
ROIC Less NNEP Spread (ROIC-NNEP)
40.65% 63.91% 70.13% 66.75% 38.96% 30.07% 53.96% 37.81% 13.91% 7.72%
Return on Net Nonoperating Assets (RNNOA)
-30.87% -48.85% -53.60% -48.64% -25.70% -18.53% -33.57% -23.22% -6.76% -2.97%
Return on Equity (ROE)
23.95% 16.07% 17.17% 19.66% 16.37% 13.46% 20.79% 15.03% 7.69% 7.03%
Cash Return on Invested Capital (CROIC)
37.63% 58.61% 50.05% 45.18% 1.34% 35.09% 48.86% 27.15% -31.07% 9.82%
Operating Return on Assets (OROA)
14.42% 16.10% 22.09% 17.06% 9.03% 9.44% 16.41% 12.32% 6.10% 5.86%
Return on Assets (ROA)
21.89% 14.92% 15.19% 17.01% 12.84% 9.56% 14.71% 10.88% 5.70% 5.29%
Return on Common Equity (ROCE)
23.95% 16.07% 17.17% 19.66% 16.37% 13.46% 20.79% 15.03% 7.69% 7.03%
Return on Equity Simple (ROE_SIMPLE)
22.66% 14.93% 16.13% 19.31% 15.04% 13.96% 19.57% 14.98% 7.53% 7.00%
Net Operating Profit after Tax (NOPAT)
103 137 172 207 178 161 277 212 109 93
NOPAT Margin
22.87% 25.84% 22.41% 25.64% 24.58% 19.82% 26.67% 21.04% 13.06% 10.16%
Net Nonoperating Expense Percent (NNEP)
14.17% 1.00% 0.64% 1.54% 3.10% 1.91% 0.40% 0.44% 0.54% 2.28%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 14.72% 7.27% 6.12%
Cost of Revenue to Revenue
22.77% 24.75% 24.45% 25.55% 26.15% 25.45% 26.74% 28.25% 28.21% 31.57%
SG&A Expenses to Revenue
34.77% 31.37% 28.81% 32.58% 37.74% 32.99% 29.83% 31.02% 40.49% 40.56%
R&D to Revenue
15.49% 14.78% 12.95% 14.44% 16.46% 16.15% 13.05% 14.03% 16.64% 15.29%
Operating Expenses to Revenue
50.26% 46.15% 41.76% 47.02% 54.20% 53.52% 42.88% 47.28% 56.18% 55.85%
Earnings before Interest and Taxes (EBIT)
123 155 257 220 143 174 312 244 121 118
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
138 170 274 242 168 202 337 269 145 151
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.24 5.32 9.12 5.55 6.72 10.89 9.45 5.59 4.74 4.05
Price to Tangible Book Value (P/TBV)
3.63 5.96 10.31 6.23 8.49 13.71 11.49 6.79 7.14 5.90
Price to Revenue (P/Rev)
5.94 9.68 13.04 7.82 12.55 16.95 13.03 7.99 8.52 6.73
Price to Earnings (P/E)
14.31 35.66 56.53 28.76 44.67 78.01 48.30 37.28 62.99 57.93
Dividend Yield
0.67% 0.49% 0.00% 0.51% 0.38% 2.83% 2.94% 0.57% 0.69% 0.85%
Earnings Yield
6.99% 2.80% 1.77% 3.48% 2.24% 1.28% 2.07% 2.68% 1.59% 1.73%
Enterprise Value to Invested Capital (EV/IC)
10.07 20.14 34.23 16.31 16.19 26.23 24.12 12.29 7.06 5.98
Enterprise Value to Revenue (EV/Rev)
4.56 8.27 11.96 6.83 11.39 16.00 12.16 7.14 7.83 6.08
Enterprise Value to EBITDA (EV/EBITDA)
14.88 25.68 33.43 22.80 49.30 64.34 37.37 26.74 45.25 36.96
Enterprise Value to EBIT (EV/EBIT)
16.67 28.24 35.66 25.05 57.65 74.61 40.39 29.43 54.07 47.34
Enterprise Value to NOPAT (EV/NOPAT)
19.94 32.00 53.37 26.64 46.32 80.73 45.60 33.93 59.95 59.88
Enterprise Value to Operating Cash Flow (EV/OCF)
16.01 24.05 40.84 24.65 32.62 53.53 40.15 29.50 58.06 37.32
Enterprise Value to Free Cash Flow (EV/FCFF)
29.05 35.44 75.47 40.28 1,457.96 73.59 50.73 47.79 0.00 60.99
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.76 -0.76 -0.76 -0.73 -0.66 -0.62 -0.62 -0.61 -0.49 -0.39
Leverage Ratio
1.09 1.08 1.13 1.16 1.27 1.41 1.41 1.38 1.35 1.33
Compound Leverage Factor
1.13 1.13 1.17 1.23 1.45 1.51 1.44 1.42 1.51 1.48
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
28.25 42.85 33.67 27.03 11.81 16.78 15.84 10.90 9.62 9.04
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
8.28 8.00 5.59 8.54 5.04 4.55 3.39 3.82 4.47 3.62
Quick Ratio
7.29 7.27 4.72 7.26 4.32 3.81 2.43 2.81 2.95 2.32
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
71 124 121 137 5.67 176 249 150 -235 91
Operating Cash Flow to CapEx
704.01% 1,420.73% 780.15% 602.38% 1,164.92% 1,822.15% 2,032.13% 1,237.64% 489.30% 991.03%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.53 0.55 0.66 0.63 0.46 0.44 0.55 0.51 0.42 0.46
Accounts Receivable Turnover
10.87 10.54 8.30 6.34 6.16 6.77 7.81 7.68 6.86 6.96
Inventory Turnover
3.08 4.08 3.95 2.73 2.64 3.41 3.19 2.41 1.66 1.81
Fixed Asset Turnover
9.08 9.87 11.60 9.52 8.03 9.62 13.24 12.80 9.03 8.95
Accounts Payable Turnover
8.18 14.82 11.25 10.38 11.13 12.09 9.19 7.99 9.73 9.70
Days Sales Outstanding (DSO)
33.59 34.65 43.95 57.56 59.28 53.91 46.75 47.51 53.20 52.48
Days Inventory Outstanding (DIO)
118.42 89.56 92.48 133.92 138.06 107.06 114.48 151.29 219.93 202.15
Days Payable Outstanding (DPO)
44.63 24.63 32.44 35.16 32.79 30.18 39.70 45.69 37.50 37.61
Cash Conversion Cycle (CCC)
107.38 99.57 103.99 156.33 164.55 130.78 121.53 153.11 235.63 217.02
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
204 217 268 338 510 495 523 584 928 930
Invested Capital Turnover
2.40 2.51 3.16 2.66 1.71 1.61 2.04 1.82 1.11 0.98
Increase / (Decrease) in Invested Capital
32 13 50 70 173 -16 28 61 344 1.68
Enterprise Value (EV)
2,055 4,378 9,162 5,507 8,262 12,977 12,610 7,182 6,556 5,564
Market Capitalization
2,677 5,124 9,990 6,305 9,107 13,744 13,518 8,036 7,132 6,151
Book Value per Share
$9.73 $11.24 $12.65 $6.59 $7.93 $7.23 $8.09 $8.32 $8.74 $8.85
Tangible Book Value per Share
$8.70 $10.03 $11.19 $5.88 $6.28 $5.74 $6.65 $6.84 $5.80 $6.07
Total Capital
826 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-622 -745 -828 -798 -845 -767 -907 -854 -576 -587
Capital Expenditures (CapEx)
18 13 29 37 22 13 15 20 23 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
42 40 113 153 75 97 128 130 195 198
Debt-free Net Working Capital (DFNWC)
391 461 517 689 487 469 451 530 527 444
Net Working Capital (NWC)
391 461 517 689 487 469 451 530 527 444
Net Nonoperating Expense (NNE)
-84 -6.86 -5.04 -13 -26 -15 -3.33 -3.84 -3.89 -13
Net Nonoperating Obligations (NNO)
-622 -745 -828 -798 -845 -767 -907 -854 -576 -587
Total Depreciation and Amortization (D&A)
15 15 17 22 24 28 25 25 24 33
Debt-free, Cash-free Net Working Capital to Revenue
9.40% 7.50% 14.73% 19.03% 10.32% 11.97% 12.30% 12.91% 23.29% 21.64%
Debt-free Net Working Capital to Revenue
86.74% 86.98% 67.53% 85.44% 67.08% 57.88% 43.51% 52.68% 62.94% 48.55%
Net Working Capital to Revenue
86.74% 86.98% 67.53% 85.44% 67.08% 57.88% 43.51% 52.68% 62.94% 48.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$1.09 $0.88 $1.02 $1.27 $1.19 $1.02 $1.59 $1.24 $0.66 $0.62
Adjusted Weighted Average Basic Shares Outstanding
172.59M 170.68M 173.29M 172.33M 171.19M 173.49M 176.46M 173.41M 172.25M 171.44M
Adjusted Diluted Earnings per Share
$1.07 $0.86 $0.99 $1.24 $1.16 $1.00 $1.56 $1.23 $0.65 $0.62
Adjusted Weighted Average Diluted Shares Outstanding
175.98M 174.14M 179.55M 177.41M 175.27M 176.59M 179.92M 174.87M 173.40M 172.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
169.77M 172.11M 173.55M 170.83M 172.61M 352.06M 347.83M 345.07M 343.27M 169.87M
Normalized Net Operating Profit after Tax (NOPAT)
103 137 172 207 100 194 277 213 109 93
Normalized NOPAT Margin
22.87% 25.84% 22.41% 25.64% 13.76% 23.95% 26.67% 21.18% 13.06% 10.16%
Pre Tax Income Margin
28.18% 30.61% 34.78% 29.09% 22.46% 23.05% 30.75% 24.92% 16.16% 14.38%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
9.66% 17.55% 16.43% 14.53% 17.23% 221.65% 15.46% 21.31% 43.34% 49.29%
Augmented Payout Ratio
77.20% 50.36% 86.44% 107.49% 47.49% 250.61% 73.22% 116.10% 113.81% 112.47%

Quarterly Metrics and Ratios for Cognex

This table displays calculated financial ratios and metrics derived from Cognex's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-26.41% -1.90% -28.78% -11.69% -5.91% -17.86% 4.81% -1.33% 19.01% 16.79%
EBITDA Growth
-52.81% 0.19% -69.48% 0.11% -37.85% -67.99% -19.15% -32.54% 52.25% 95.53%
EBIT Growth
-56.32% 1.05% -73.76% 1.23% -41.70% -77.45% -36.16% -39.62% 49.22% 146.42%
NOPAT Growth
-55.67% -2.83% -67.48% -7.21% -37.91% -80.38% -55.11% -39.38% 19.05% 145.22%
Net Income Growth
-56.93% 3.32% -61.96% -2.42% -44.33% -79.70% -53.07% -36.99% 56.43% 152.44%
EPS Growth
-56.82% 6.67% -60.53% -2.94% -42.11% -81.25% -53.33% -36.36% 54.55% 183.33%
Operating Cash Flow Growth
30.23% 20.01% -44.36% -32.33% -50.88% -78.13% -50.48% -6.99% 37.17% 254.73%
Free Cash Flow Firm Growth
-146.62% -144.01% 6.35% 114.17% -69.48% -3,032.56% -1,880.02% -3,046.33% -483.77% 106.80%
Invested Capital Growth
12.61% 11.75% 6.70% 7.66% 12.49% 58.95% 54.80% 46.83% 49.29% 0.18%
Revenue Q/Q Growth
-23.67% 14.22% -16.00% 20.58% -18.67% -0.29% 7.18% 13.52% -1.90% -2.15%
EBITDA Q/Q Growth
-36.18% 42.70% -55.06% 144.61% -60.38% -26.49% 13.50% 104.11% -10.60% -5.60%
EBIT Q/Q Growth
-39.71% 50.03% -60.24% 181.43% -65.28% -41.96% 12.56% 166.18% -14.19% -4.15%
NOPAT Q/Q Growth
-41.97% 46.80% -57.32% 155.23% -61.17% -53.60% -2.38% 244.63% -23.73% -4.43%
Net Income Q/Q Growth
-42.31% 62.78% -53.69% 124.38% -67.09% -40.64% 7.06% 201.21% -18.28% -4.21%
EPS Q/Q Growth
-44.12% 68.42% -53.13% 120.00% -66.67% -45.45% 16.67% 200.00% -19.05% 0.00%
Operating Cash Flow Q/Q Growth
89.34% -20.67% -58.42% 8.33% 37.44% -64.68% -5.85% 103.50% 102.68% -8.65%
Free Cash Flow Firm Q/Q Growth
54.44% 63.75% -51.61% 156.61% -644.76% -569.97% 4.17% 15.76% -7.94% 107.80%
Invested Capital Q/Q Growth
-5.04% 2.20% 3.13% 7.57% -0.78% 44.41% 0.44% 2.02% 0.89% -3.09%
Profitability Metrics
- - - - - - - - - -
Gross Margin
72.63% 70.82% 71.47% 74.09% 72.39% 68.67% 67.33% 69.62% 67.90% 68.73%
EBITDA Margin
21.02% 26.26% 14.05% 28.50% 13.88% 10.23% 10.84% 19.49% 17.76% 17.13%
Operating Margin
19.09% 22.69% 11.02% 26.88% 15.53% 6.47% 6.74% 16.07% 13.45% 13.43%
EBIT Margin
18.09% 23.77% 11.25% 26.26% 11.21% 6.53% 6.85% 16.07% 14.06% 13.77%
Profit (Net Income) Margin
16.21% 23.10% 12.74% 23.70% 9.59% 5.71% 5.70% 15.13% 12.61% 12.34%
Tax Burden Percent
86.36% 93.38% 97.71% 84.80% 70.05% 78.23% 68.44% 87.12% 80.95% 79.18%
Interest Burden Percent
103.73% 104.09% 115.85% 106.43% 122.12% 111.84% 121.60% 108.10% 110.79% 113.20%
Effective Tax Rate
13.64% 6.62% 2.29% 15.20% 29.95% 21.77% 31.56% 12.88% 19.05% 20.82%
Return on Invested Capital (ROIC)
30.89% 38.53% 17.06% 32.55% 15.77% 5.61% 5.09% 14.78% 11.97% 10.46%
ROIC Less NNEP Spread (ROIC-NNEP)
30.95% 38.01% 16.58% 32.28% 16.08% 5.43% 4.76% 14.38% 11.42% 9.79%
Return on Net Nonoperating Assets (RNNOA)
-19.36% -23.34% -9.68% -18.22% -9.29% -2.64% -2.27% -6.68% -5.43% -3.77%
Return on Equity (ROE)
11.52% 15.18% 7.38% 14.33% 6.48% 2.97% 2.82% 8.09% 6.54% 6.69%
Cash Return on Invested Capital (CROIC)
27.59% 27.15% 22.11% 18.65% 13.01% -31.07% -30.44% -28.58% -29.75% 9.82%
Operating Return on Assets (OROA)
9.26% 12.07% 5.32% 11.90% 5.07% 2.75% 2.91% 6.78% 6.11% 6.28%
Return on Assets (ROA)
8.30% 11.73% 6.03% 10.74% 4.34% 2.41% 2.42% 6.38% 5.48% 5.63%
Return on Common Equity (ROCE)
11.52% 15.18% 7.38% 14.33% 6.48% 2.97% 2.82% 8.09% 6.54% 6.69%
Return on Equity Simple (ROE_SIMPLE)
15.39% 0.00% 12.02% 11.64% 10.57% 0.00% 6.69% 5.20% 5.68% 0.00%
Net Operating Profit after Tax (NOPAT)
35 51 22 55 21 9.96 9.72 34 26 24
NOPAT Margin
16.49% 21.19% 10.77% 22.79% 10.88% 5.06% 4.61% 14.00% 10.88% 10.63%
Net Nonoperating Expense Percent (NNEP)
-0.07% 0.52% 0.48% 0.27% -0.31% 0.18% 0.33% 0.39% 0.56% 0.68%
Return On Investment Capital (ROIC_SIMPLE)
- 3.53% - - - 0.66% - - - 1.61%
Cost of Revenue to Revenue
27.37% 29.18% 28.53% 25.91% 27.61% 31.33% 32.67% 30.38% 32.10% 31.27%
SG&A Expenses to Revenue
35.96% 31.72% 41.29% 34.40% 41.73% 45.95% 42.99% 38.94% 39.46% 41.14%
R&D to Revenue
16.20% 15.51% 19.16% 13.85% 16.52% 17.64% 17.60% 14.61% 15.00% 14.17%
Operating Expenses to Revenue
53.53% 48.12% 60.45% 47.22% 56.85% 62.19% 60.60% 53.55% 54.46% 55.30%
Earnings before Interest and Taxes (EBIT)
38 57 23 64 22 13 14 38 33 32
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
44 63 28 69 27 20 23 47 42 39
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
5.11 5.59 5.85 6.47 4.88 4.74 4.89 5.32 4.41 4.05
Price to Tangible Book Value (P/TBV)
6.21 6.79 7.09 7.80 5.86 7.14 7.29 7.80 6.44 5.90
Price to Revenue (P/Rev)
7.02 7.99 9.15 10.73 8.24 8.52 8.59 9.49 7.83 6.73
Price to Earnings (P/E)
33.18 37.28 48.68 55.59 46.13 62.99 73.03 102.21 77.55 57.93
Dividend Yield
0.64% 0.57% 0.55% 0.50% 0.66% 0.69% 0.69% 0.63% 0.75% 0.85%
Earnings Yield
3.01% 2.68% 2.05% 1.80% 2.17% 1.59% 1.37% 0.98% 1.29% 1.73%
Enterprise Value to Invested Capital (EV/IC)
10.98 12.29 12.64 13.50 9.97 7.06 7.21 7.84 6.56 5.98
Enterprise Value to Revenue (EV/Rev)
6.21 7.14 8.24 9.80 7.28 7.83 7.93 8.83 7.15 6.08
Enterprise Value to EBITDA (EV/EBITDA)
23.38 26.74 37.30 42.83 34.17 45.25 48.18 63.74 47.98 36.96
Enterprise Value to EBIT (EV/EBIT)
25.78 29.43 42.23 48.31 38.78 54.07 59.43 84.88 63.80 47.34
Enterprise Value to NOPAT (EV/NOPAT)
29.48 33.93 45.65 53.80 42.63 59.95 69.61 99.55 80.28 59.88
Enterprise Value to Operating Cash Flow (EV/OCF)
27.01 29.50 34.40 42.24 38.93 58.06 67.87 76.93 56.16 37.32
Enterprise Value to Free Cash Flow (EV/FCFF)
42.15 47.79 59.03 75.08 81.13 0.00 0.00 0.00 0.00 60.99
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.63 -0.61 -0.58 -0.56 -0.58 -0.49 -0.48 -0.46 -0.48 -0.39
Leverage Ratio
1.37 1.38 1.39 1.37 1.35 1.35 1.36 1.34 1.33 1.33
Compound Leverage Factor
1.42 1.44 1.61 1.46 1.65 1.51 1.65 1.45 1.47 1.50
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
9.70 10.59 10.80 12.36 9.95 9.45 9.41 10.82 9.48 8.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
4.88 3.82 3.38 3.98 4.99 4.47 3.52 4.03 3.94 3.62
Quick Ratio
3.55 2.81 2.46 2.88 3.80 2.95 2.23 2.67 2.62 2.32
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-29 -11 -16 9.16 -50 -334 -320 -270 -291 23
Operating Cash Flow to CapEx
1,919.12% 1,631.14% 500.33% 635.09% 700.65% 206.57% 335.95% 615.59% 1,279.18% 2,479.69%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.51 0.51 0.47 0.45 0.45 0.42 0.43 0.42 0.44 0.46
Accounts Receivable Turnover
8.58 7.68 6.10 5.51 7.64 6.86 5.89 5.42 6.03 6.96
Inventory Turnover
2.99 2.41 1.99 2.23 2.02 1.66 1.66 1.82 1.93 1.81
Fixed Asset Turnover
12.93 12.80 11.62 11.08 10.84 9.03 9.14 9.14 9.47 8.95
Accounts Payable Turnover
11.56 7.99 7.33 10.65 10.80 9.73 9.11 10.58 10.50 9.70
Days Sales Outstanding (DSO)
42.53 47.51 59.88 66.19 47.80 53.20 62.00 67.31 60.50 52.48
Days Inventory Outstanding (DIO)
122.18 151.29 183.21 163.90 180.91 219.93 219.50 200.80 189.46 202.15
Days Payable Outstanding (DPO)
31.57 45.69 49.78 34.27 33.79 37.50 40.07 34.51 34.75 37.61
Cash Conversion Cycle (CCC)
133.14 153.11 193.31 195.82 194.92 235.63 241.43 233.59 215.21 217.02
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
572 584 602 648 643 928 933 951 960 930
Invested Capital Turnover
1.87 1.82 1.58 1.43 1.45 1.11 1.10 1.06 1.10 0.98
Increase / (Decrease) in Invested Capital
64 61 38 46 71 344 330 303 317 1.68
Enterprise Value (EV)
6,276 7,182 7,617 8,750 6,412 6,556 6,720 7,456 6,299 5,564
Market Capitalization
7,093 8,036 8,461 9,583 7,258 7,132 7,276 8,011 6,906 6,151
Book Value per Share
$8.01 $8.32 $8.38 $8.58 $8.64 $8.74 $8.67 $8.78 $9.14 $8.85
Tangible Book Value per Share
$6.59 $6.84 $6.91 $7.12 $7.18 $5.80 $5.81 $5.98 $6.26 $6.07
Total Capital
1,389 1,438 1,446 1,480 1,489 1,505 1,489 1,507 1,567 1,518
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-818 -854 -844 -832 -846 -576 -557 -555 -607 -587
Capital Expenditures (CapEx)
4.35 4.06 5.51 4.70 5.86 7.02 4.06 4.51 4.40 2.07
Debt-free, Cash-free Net Working Capital (DFCFNWC)
152 130 127 169 165 195 195 223 213 198
Debt-free Net Working Capital (DFNWC)
626 530 508 538 677 527 473 512 501 444
Net Working Capital (NWC)
626 530 508 538 677 527 473 512 501 444
Net Nonoperating Expense (NNE)
0.59 -4.57 -3.96 -2.21 2.55 -1.27 -2.30 -2.71 -4.04 -3.93
Net Nonoperating Obligations (NNO)
-818 -854 -844 -832 -846 -576 -557 -555 -607 -587
Total Depreciation and Amortization (D&A)
6.13 5.97 5.63 5.43 5.27 7.29 8.40 8.18 8.69 7.73
Debt-free, Cash-free Net Working Capital to Revenue
15.01% 12.91% 13.77% 18.93% 18.70% 23.29% 23.04% 26.44% 24.22% 21.64%
Debt-free Net Working Capital to Revenue
61.95% 52.68% 54.95% 60.26% 76.94% 62.94% 55.88% 60.69% 56.87% 48.55%
Net Working Capital to Revenue
61.95% 52.68% 54.95% 60.26% 76.94% 62.94% 55.88% 60.69% 56.87% 48.55%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.31 $0.15 $0.33 $0.11 $0.07 $0.07 $0.21 $0.17 $0.17
Adjusted Weighted Average Basic Shares Outstanding
173.26M 173.41M 172.62M 172.43M 172.17M 172.25M 171.69M 171.57M 171.52M 171.44M
Adjusted Diluted Earnings per Share
$0.19 $0.32 $0.15 $0.33 $0.11 $0.06 $0.07 $0.21 $0.17 $0.17
Adjusted Weighted Average Diluted Shares Outstanding
174.33M 174.87M 173.90M 173.62M 173.35M 173.40M 172.59M 172.73M 172.75M 172.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
172.93M 345.07M 172.60M 172.29M 172.14M 343.27M 171.66M 171.50M 171.52M 169.87M
Normalized Net Operating Profit after Tax (NOPAT)
35 51 22 55 21 9.96 9.72 34 26 24
Normalized NOPAT Margin
16.49% 21.19% 10.77% 22.79% 10.88% 5.06% 4.61% 14.00% 10.88% 10.63%
Pre Tax Income Margin
18.77% 24.74% 13.03% 27.95% 13.69% 7.30% 8.33% 17.37% 15.57% 15.59%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
21.19% 21.31% 26.87% 27.56% 30.70% 43.34% 50.06% 64.65% 57.82% 49.29%
Augmented Payout Ratio
157.68% 116.10% 83.31% 85.08% 85.09% 113.81% 115.24% 129.10% 107.22% 112.47%

Frequently Asked Questions About Cognex's Financials

When does Cognex's financial year end?

According to the most recent income statement we have on file, Cognex's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Cognex's net income changed over the last 9 years?
The last 5 years of Cognex's net income performance:
  • 2020: $176.19 million
  • 2021: $279.88 million
  • 2022: $215.53 million
  • 2023: $113.23 million
  • 2024: $106.17 million
What is Cognex's operating income?
Cognex's total operating income in 2024 was $115.07 million, based on the following breakdown:
  • Total Gross Profit: $625.79 million
  • Total Operating Expenses: $510.73 million
How has Cognex revenue changed over the last 9 years?

Over the last 9 years, Cognex's total revenue changed from $450.56 million in 2015 to $914.52 million in 2024, a change of 103.0%.

How much debt does Cognex have?

Cognex's total liabilities were at $475.35 million at the end of 2024, a 7.4% decrease from 2023, and a 665.6% increase since 2015.

How much cash does Cognex have?

In the past 9 years, Cognex's cash and equivalents has ranged from $51.98 million in 2015 to $269.07 million in 2020, and is currently $186.09 million as of their latest financial filing in 2024.

How has Cognex's book value per share changed over the last 9 years?

Over the last 9 years, Cognex's book value per share changed from 9.73 in 2015 to 8.85 in 2024, a change of -9.1%.



This page (NASDAQ:CGNX) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners